Citius Pharmaceuticals, Inc. (CTXR) Misses Q3 EPS by 1c

August 13, 2024 7:01 AM EDT

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Citi, Earnings, Maynard Um, Mark Zuckerberg, ARK